Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
Novo-Nordisk A/S · Now $45.58
+2.9% in 7d after detection
Post-detection moves
1h
—
1d
+1.8%
3d
+1.5%
7d
+2.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS